Literature DB >> 26874455

Pathogen-driven treatment strategy in new onset dilated cardiomyopathy. Impact on ventricular function and clinical outcome.

Aggeliki Gkouziouta1, George Lazaros2, Apostolos Karavidas3, George Georgiopoulos4, Dimitrios Miliopoulos1, George Karavolias1, Malena Pantou5, Sophia Hatzianastasiou1, George Saroglou1, Vassilis Voudris1, Stamatis Adamopoulos1.   

Abstract

Entities:  

Keywords:  Dilated cardiomyopathy; Endomyocardial biopsy; Infective agents; Prognosis; Specific antimicrobial treatment

Mesh:

Substances:

Year:  2016        PMID: 26874455     DOI: 10.1016/j.ijcard.2016.02.032

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  2 in total

Review 1.  Left ventricular ejection fraction as therapeutic target: is it the ideal marker?

Authors:  V Katsi; G Georgiopoulos; A Laina; E Koutli; J Parissis; C Tsioufis; P Nihoyannopoulos; D Tousoulis
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

2.  Rhinovirus-associated dilated cardiomyopathy.

Authors:  Jeffrey Chow; Joey Murphy; Ashish Subedi; Amudhan Jyothidasan
Journal:  IDCases       Date:  2020-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.